Investigational Site Number :5280002

Amsterdam 1105 AZ

1 studies enrolling now · 7 studies all time

What they study most

Acute Lymphocytic Leukaemia, Acute Myeloid Leukaemia Refractory, Autoimmune Haemolytic Anaemia, Blastic Plasmacytoid Dendritic Cell Neoplasia, Breast Cancer Metastatic, Chronic Rhinosinusitis With Nasal Polyps, Hemophilia A, Myelodysplastic Syndromes, Pancreatic Carcinoma Metastatic, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia — Recruiting now
• Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A — Running, not enrolling
• First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) — Stopped early
• A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps — Running, not enrolling
• Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors — Stopped early
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204) — Stopped early
• Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A — Completed